Frederiksstaden Pharma ApS

  • Active

  • Registration 25630483
  • APS
  • Established 20 September, 2000

Company information

Legal form
Anpartsselskab (APS)
Status

Active

 Established 20 September, 2000
Address
Frederiksgade 11, st.th
1265 København K
Denmark
Phone: 36495500
Registration number
Registration 25630483

Relations

Past relations
Ultimate beneficial owners (UBOs)
  • Jens-Nikolaj Schøier
    2019-12-02 – 25.83% ownership (2021-05-01 – 2022-01-27 ) 27.17% ownership (2019-12-27 – 2021-04-30 ) 39.5% ownership (2022-01-28 – ) 43.12% ownership (2019-12-02 – 2019-12-26 ) 25.83% voting rights (2021-05-01 – 2022-01-27 ) 27.17% voting rights (2019-12-27 – 2021-04-30 ) 39.5% voting rights (2022-01-28 – ) 43.12% voting rights (2019-12-02 – 2019-12-26 )
  • Mohammad Sohail Asghar
    2019-12-02 – 25.83% ownership (2021-05-01 – 2022-01-27 ) 27.17% ownership (2019-12-27 – 2021-04-30 ) 39.5% ownership (2022-01-28 – ) 43.12% ownership (2019-12-02 – 2019-12-26 ) 25.83% voting rights (2021-05-01 – 2022-01-27 ) 27.17% voting rights (2019-12-27 – 2021-04-30 ) 39.5% voting rights (2022-01-28 – ) 43.12% voting rights (2019-12-02 – 2019-12-26 )
  • Henrik Grundtvig
    2019-07-01 – 2019-11-22 10% ownership (2019-07-01 – 2019-11-22 ) 50% voting rights (2019-07-01 – 2019-11-22 )
  • Michael Grundtvig
    2019-07-01 – 2019-11-22 10% ownership (2019-07-01 – 2019-11-22 ) 50% voting rights (2019-07-01 – 2019-11-22 )
  • Bente Grundtvig
    2019-01-15 – 2019-07-01 73.65% ownership (2019-01-15 – 2019-06-24 ) 100% ownership (2019-06-25 – 2019-07-01 ) 73.65% voting rights (2019-01-15 – 2019-06-24 ) 100% voting rights (2019-06-25 – 2019-07-01 )
  • Helle Bøwadt
    2000-09-20 – 2019-06-25 26.35% ownership (2000-09-20 – 2019-06-25 ) 26.35% voting rights (2000-09-20 – 2019-06-25 )
  • Lars Grundtvig
    2016-04-26 – 2019-01-15 73.65% ownership (2016-04-26 – 2019-01-15 ) 73.65% voting rights (2016-04-26 – 2019-01-15 )
Legal owners
  • CAND.PHARM. POVL M. ASSENS FOND 33.33% ownership (2019-12-27 – 2022-04-27 ) 33.33% voting rights (2019-12-27 – 2022-04-27 )
  • XGX Pharma ApS 100% ownership (2019-11-22 – 2019-12-26 ) 50% ownership (2019-12-27 – 2022-04-26 ) 100% voting rights (2019-11-22 – 2019-12-26 ) 50% voting rights (2019-12-27 – 2022-04-26 )
  • Felumb Holding ApS 10% ownership (2020-05-01 – 2021-05-01 ) 10% voting rights (2020-05-01 – 2021-05-01 )
  • XGX Pharma ApS 100% ownership (2019-11-22 – 2019-12-26 ) 50% ownership (2019-12-27 – 2022-04-26 ) 100% voting rights (2019-11-22 – 2019-12-26 ) 50% voting rights (2019-12-27 – 2022-04-26 )
  • HB MEDICAL SCANDINAVIA A/S 100% ownership (2016-04-26 – 2019-11-22 ) 100% voting rights (2016-04-26 – 2019-11-22 )
  • HB-MEDICAL HOLDING ApS 66.67% ownership (2000-09-20 – 2016-04-25 ) 66.67% voting rights (2000-09-20 – 2016-04-25 )
  • Kjær Henningsen Holding ApS 10% ownership (2015-08-14 – 2016-04-25 ) 10% voting rights (2015-08-14 – 2016-04-25 )
Directors
Board members

Employees

Frederiksstaden Pharma ApS has 1.59 full time equivalents (FTEs) and 2.00 employees as of 1 September, 2021.

Financial reports

Revenue
Profit/loss
'000 12-2012 12-2013 12-2014 09-2015 04-2016 04-2017 04-2018
Currency DKK DKK DKK DKK DKK DKK DKK
Revenue 0 0 0 0 0 0 0
Raw materials and consumables used 0 0 0 0 0 0 0
Other external expenses 0 0 0 0 0 0 0
Gross profit loss 6,659 3,825 3,544 0 0 0 0
Employee benefits expense 6,455 5,775 3,460 0 0 0 0
Wages and salaries 0 0 0 0 0 0 0
Depreciation amortisation expense and impairment losses of prop 0 0 0 0 0 0 0
Profit loss from ordinary operating activities 71 -2,227 -62 0 0 0 0
Profit loss from ordinary activities before tax 55 -2,329 -262 0 0 0 0
Other finance expenses 16 107 199 0 0 0 0
Tax expense 0 0 0 0 0 0 0
Profit loss 40 -2,327 -286 0 0 0 0